Terms: = Pancreatic cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
305 results:
1. Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).
Imai H; Sakamoto Y; Takahashi S; Shibata H; Sato A; Otsuka K; Amagai K; Takahashi M; Yamaguchi T; Ishioka C
BMC Cancer; 2024 Feb; 24(1):262. PubMed ID: 38402399
[TBL] [Abstract] [Full Text] [Related]
2. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial.
Zhang D; Benedikt Westphalen C; Quante M; Waldschmidt DT; Held S; Kütting F; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Boeck S; Heinemann V; Probst V
Eur J Cancer; 2024 Apr; 201():113926. PubMed ID: 38401449
[TBL] [Abstract] [Full Text] [Related]
3. Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study.
Gumpper-Fedus K; Chasser K; Pita-Grisanti V; Torok M; Pfau T; Mace TA; Cole RM; Belury MA; Culp S; Hart PA; Krishna SG; Lara LF; Ramsey ML; Fisher W; Fogel EL; Forsmark CE; Li L; Pandol S; Park WG; Serrano J; Van Den Eeden SK; Vege SS; Yadav D; Conwell DL; Cruz-Monserrate Z;
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00686. PubMed ID: 38284831
[TBL] [Abstract] [Full Text] [Related]
4. Chimeric Antigen Receptor T Cell Therapy for pancreatic cancer: A Review of Current Evidence.
Czaplicka A; Lachota M; Pączek L; Zagożdżon R; Kaleta B
Cells; 2024 Jan; 13(1):. PubMed ID: 38201305
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in cancer.
Tanabe S; Boonstra E; Hong T; Quader S; Ono R; Cabral H; Aoyagi K; Yokozaki H; Perkins EJ; Sasaki H
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003016
[TBL] [Abstract] [Full Text] [Related]
6. Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells.
Szymoński K; Skirlińska-Nosek K; Lipiec E; Sofińska K; Czaja M; Wilkosz N; Krupa M; Wanat F; Ulatowska-Białas M; Adamek D
Anal Bioanal Chem; 2023 Dec; 415(29-30):7281-7295. PubMed ID: 37906289
[TBL] [Abstract] [Full Text] [Related]
7. Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: results from the national mortality surveillance system.
Xu Y; Liu W; Long Z; Wang L; Zhou M; Yin P
BMC Cancer; 2023 Sep; 23(1):893. PubMed ID: 37735368
[TBL] [Abstract] [Full Text] [Related]
8. KRAS
Yeh C; Park W; Yaeger R
Dev Cell; 2023 Sep; 58(17):1515-1516. PubMed ID: 37699334
[TBL] [Abstract] [Full Text] [Related]
9. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract] [Full Text] [Related]
10. Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing fas-dependent apoptosis by CD8
Mahadevan KK; LeBleu VS; Ramirez EV; Chen Y; Li B; Sockwell AM; Gagea M; Sugimoto H; Sthanam LK; Tampe D; Zeisberg M; Ying H; Jain AK; DePinho RA; Maitra A; McAndrews KM; Kalluri R
Dev Cell; 2023 Sep; 58(17):1562-1577.e8. PubMed ID: 37625403
[TBL] [Abstract] [Full Text] [Related]
11. KRAS
Mahadevan KK; McAndrews KM; LeBleu VS; Yang S; Lyu H; Li B; Sockwell AM; Kirtley ML; Morse SJ; Moreno Diaz BA; Kim MP; Feng N; Lopez AM; Guerrero PA; Paradiso F; Sugimoto H; Arian KA; Ying H; Barekatain Y; Sthanam LK; Kelly PJ; Maitra A; Heffernan TP; Kalluri R
Cancer Cell; 2023 Sep; 41(9):1606-1620.e8. PubMed ID: 37625401
[TBL] [Abstract] [Full Text] [Related]
12. Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion.
Falls SJ; Maxwell CM; Kaye DJ; Dighe SG; Schiffman SC; Bartlett DL; Wagner PL; Allen CJ
Am Surg; 2024 Jan; 90(1):85-91. PubMed ID: 37578387
[TBL] [Abstract] [Full Text] [Related]
13. Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models.
Wang T; Zhang K; You F; Ma R; Yang N; Tian S; An G; Yang L
Life Sci; 2023 Oct; 331():122024. PubMed ID: 37574043
[TBL] [Abstract] [Full Text] [Related]
14. The prognostic effect of the systemic immune-inflammation index on overall survival of periampullary cancer.
Yur M; Balin ŞÖ; Aygen E; Ilhan YS; Yilmaz S; Ebiloğlu MF
Curr Med Res Opin; 2023 Aug; 39(8):1139-1145. PubMed ID: 37470473
[TBL] [Abstract] [Full Text] [Related]
15. The Postoperative Utilization of Intensive Care Beds After Visceral Surgery Procedures.
Peters F; Hohenstein S; Bollmann A; Kuhlen R; Ritz JP
Dtsch Arztebl Int; 2023 Sep; 120(38):633-638. PubMed ID: 37427992
[TBL] [Abstract] [Full Text] [Related]
16. External validation of genetically predicted protein biomarkers for pancreatic cancer risk using aptamer-based plasma levels: A prospective analysis in the Atherosclerosis Risk in Communities Study.
Liu T; Joshu CE; Lu J; Prizment A; Chatterjee N; Coresh J; Wu L; Platz EA
Int J Cancer; 2023 Sep; 153(6):1201-1216. PubMed ID: 37338014
[TBL] [Abstract] [Full Text] [Related]
17. Novel Isotope-Labeled Derivatization Strategy for the Simultaneous Analysis of Fatty Acids and Fatty Alcohols and Its Application in Idiopathic Inflammatory Myopathies and pancreatic cancer.
Pu Q; Wang M; Jiang N; Luo Y; Li X; Hu C; Du D
Anal Chem; 2023 May; 95(21):8197-8205. PubMed ID: 37191225
[TBL] [Abstract] [Full Text] [Related]
18. Dietary sugar consumption and health: umbrella review.
Huang Y; Chen Z; Chen B; Li J; Yuan X; Li J; Wang W; Dai T; Chen H; Wang Y; Wang R; Wang P; Guo J; Dong Q; Liu C; Wei Q; Cao D; Liu L
BMJ; 2023 Apr; 381():e071609. PubMed ID: 37019448
[TBL] [Abstract] [Full Text] [Related]
19. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract] [Full Text] [Related]
20. PW06 Triggered fas-FADD to Induce Apoptotic Cell Death In Human pancreatic Carcinoma MIA
Huang YP; Hsia TC; Yeh CA; Ma YS; Hsu SY; Liu YC; Lyu PC; Lai KC; Peng SF; Lien JC; Hsieh WT
Oxid Med Cell Longev; 2023; 2023():3479688. PubMed ID: 36820406
[TBL] [Abstract] [Full Text] [Related]
[Next]
